Catalyst Pharmaceuticals
CPRX
#3815
Rank
$2.58 B
Marketcap
$21.80
Share price
1.11%
Change (1 day)
78.69%
Change (1 year)

Operating Margin for Catalyst Pharmaceuticals (CPRX)

Operating Margin as of October 2024 (TTM): 21.53%

According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 21.53%. At the end of 2023 the company had an Operating Margin of 23.73%.

Operating Margin history for Catalyst Pharmaceuticals from 2019 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202323.73%-51.45%
202248.89%30.73%
202137.40%6.3%
202035.18%7.73%
201932.66%-100.48%
2018-6,800.70%
2010-819.36%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
11.53%-46.45%๐Ÿ‡บ๐Ÿ‡ธ USA
4.13%-80.82%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-17.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.50%-492.48%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
15.98%-25.78%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.